Literature DB >> 18560370

Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women.

S B Pedersen1, J Ølholm, S K Paulsen, M F Bennetzen, B Richelsen.   

Abstract

OBJECTIVE: Calorie restriction increases the life span in a number of different organisms. This effect is dependent upon activation of the Sirt1 enzyme, and many of the beneficial effects of calorie restriction can be mimicked using resveratrol, which activates the Sirt1 enzyme. Nothing is known about this system in human adipose tissue; therefore, we investigated this system in human adipose tissue.
DESIGN: Sirt1 mRNA was measured in adipose tissue biopsies from human volunteers before and after 6 days of total fasting. In addition, adipose tissue from lean and obese individuals was compared and in vitro investigations were performed.
RESULTS: Long-term total fasting (6 days) of nine human volunteers increased Sirt1 mRNA expression in subcutaneous adipose tissue more than twofold (0.197-0.454 arbitrary units, P<0.05). Likewise, lean women (n=12) had more than twofold higher Sirt1 expression in subcutaneous adipose tissue compared to obese women (n=12; 0.33-0.73 arbitrary units, P<0.05). Sirt1 was equally expressed in the stroma-vascular fraction and the isolated adipocyte fraction. Finally, in vitro, we demonstrated that resveratrol (a Sirt1 activator) significantly enhanced the lipolytic effect of epinephrine in human adipose tissue (P<0.05).
CONCLUSION: Human adipose tissue contains Sirt1 and the expression of Sirt1 can be regulated by calorie restriction as in other species. Furthermore, we demonstrated that resveratrol affects human fat-cell metabolism similar to the effects in rodents (that is, increased epinephrine induced lipolysis). These findings indicated that the beneficial effects of calorie restriction in humans might involve the activation of Sirt1. Thus, based on these findings, we propose that Sirt1 might play important roles for the beneficial effects of calorie restriction in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560370     DOI: 10.1038/ijo.2008.78

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  35 in total

Review 1.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

2.  Prostaglandin E2 down-regulates sirtuin 1 (SIRT1), leading to elevated levels of aromatase, providing insights into the obesity-breast cancer connection.

Authors:  Kotha Subbaramaiah; Neil M Iyengar; Monica Morrow; Olivier Elemento; Xi Kathy Zhou; Andrew J Dannenberg
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

Review 3.  Sirtuins and their relevance to the kidney.

Authors:  Chuan-Ming Hao; Volker H Haase
Journal:  J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 10.121

4.  SIRT1 and SIRT7 expression in adipose tissues of obese and normal-weight individuals is regulated by microRNAs but not by methylation status.

Authors:  A Kurylowicz; M Owczarz; J Polosak; M I Jonas; W Lisik; M Jonas; A Chmura; M Puzianowska-Kuznicka
Journal:  Int J Obes (Lond)       Date:  2016-08-02       Impact factor: 5.095

5.  Sirtuins 1-7 expression in human adipose-derived stem cells from subcutaneous and visceral fat depots: influence of obesity and hypoxia.

Authors:  Stefania Mariani; Giuliana Di Rocco; Gabriele Toietta; Matteo A Russo; Elisa Petrangeli; Luisa Salvatori
Journal:  Endocrine       Date:  2016-11-14       Impact factor: 3.633

Review 6.  SIRT1 and other sirtuins in metabolism.

Authors:  Hung-Chun Chang; Leonard Guarente
Journal:  Trends Endocrinol Metab       Date:  2013-12-30       Impact factor: 12.015

7.  SIRT1 gene variants are related to risk of childhood obesity.

Authors:  Ulkan Kilic; Ozlem Gok; Birsen Elibol-Can; Ilker Tolga Ozgen; Ufuk Erenberk; Omer Uysal; Mehmet Rusen Dundaroz
Journal:  Eur J Pediatr       Date:  2014-09-20       Impact factor: 3.183

8.  SIRT1 genetic variation is related to BMI and risk of obesity.

Authors:  M Carola Zillikens; Joyce B J van Meurs; Fernando Rivadeneira; Najaf Amin; Albert Hofman; Ben A Oostra; Eric J G Sijbrands; Jacqueline C M Witteman; Huibert A P Pols; Cornelia M van Duijn; André G Uitterlinden
Journal:  Diabetes       Date:  2009-09-09       Impact factor: 9.461

9.  Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells.

Authors:  Saioa Gomez-Zorita; Karine Tréguer; Josep Mercader; Christian Carpéné
Journal:  J Physiol Biochem       Date:  2013-01-13       Impact factor: 4.158

10.  Circulating SIRT1 Increases After Intragastric Balloon Fat Loss in Obese Patients.

Authors:  Stefania Mariani; Daniela Fiore; Agnese Persichetti; Sabrina Basciani; Carla Lubrano; Eleonora Poggiogalle; Alfredo Genco; Lorenzo Maria Donini; Lucio Gnessi
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.